+

WO2013039994A3 - Apparatus, composition, and related methods for transdermal delivery of active ingredients - Google Patents

Apparatus, composition, and related methods for transdermal delivery of active ingredients Download PDF

Info

Publication number
WO2013039994A3
WO2013039994A3 PCT/US2012/054795 US2012054795W WO2013039994A3 WO 2013039994 A3 WO2013039994 A3 WO 2013039994A3 US 2012054795 W US2012054795 W US 2012054795W WO 2013039994 A3 WO2013039994 A3 WO 2013039994A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredients
composition
skin
hydrogel
transdermal delivery
Prior art date
Application number
PCT/US2012/054795
Other languages
French (fr)
Other versions
WO2013039994A2 (en
Inventor
Robert Davidson
Eric Allen
Edward MALISKI
Jose BERNARDO
Original Assignee
Cure Pharmaceutical Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cure Pharmaceutical Corp. filed Critical Cure Pharmaceutical Corp.
Priority to US14/344,455 priority Critical patent/US20150174068A1/en
Publication of WO2013039994A2 publication Critical patent/WO2013039994A2/en
Publication of WO2013039994A3 publication Critical patent/WO2013039994A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

In accordance with a composition aspect of the invention, a composition for applying to skin comprises one or more pharmaceutically active ingredients contained in a plurality of hydrophobic carriers dispersed throughout a hydrogel, a skin permeation enhancer for enhancing the permeation of the active ingredients into skin, and an emulsifier. The amount of hydrogel is sufficient to allow the hydrogel to dry to as a substantially continuous film over and in contact with the skin to which it is applied. Related method and apparatus aspects are also described.
PCT/US2012/054795 2011-09-12 2012-09-12 Apparatus, composition, and related methods for transdermal delivery of active ingredients WO2013039994A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/344,455 US20150174068A1 (en) 2011-09-12 2012-09-12 Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161533278P 2011-09-12 2011-09-12
US61/533,278 2011-09-12

Publications (2)

Publication Number Publication Date
WO2013039994A2 WO2013039994A2 (en) 2013-03-21
WO2013039994A3 true WO2013039994A3 (en) 2013-05-16

Family

ID=47883937

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/054795 WO2013039994A2 (en) 2011-09-12 2012-09-12 Apparatus, composition, and related methods for transdermal delivery of active ingredients

Country Status (2)

Country Link
US (1) US20150174068A1 (en)
WO (1) WO2013039994A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180161562A1 (en) * 2016-12-09 2018-06-14 Eduard Gorenshteyn Methods for cosmetic, galvanic bath-assisted transfer of biologically-active substances
WO2019175290A1 (en) 2018-03-13 2019-09-19 Beckley Canopy Therapeutics Limited Cannabis or cannabis derived compositions for promoting cessation of chemical dependence

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188900A (en) * 1985-04-04 1987-10-14 Int Genetic Sciences Fusogenic phospholipid vesicles
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080003273A1 (en) * 2006-06-29 2008-01-03 Kimberly-Clark Worldwide, Inc. Transdermal Delivery of Oleocanthal for Relief of Inflammation
KR20080016186A (en) * 2006-08-18 2008-02-21 조봉상 Cosmetic composition comprising coenzyme A, L-carnitine and caffeine mixture having a lipolytic function, IJUF-1 and white willow foil extract having a natural peeling function.
WO2011039630A1 (en) * 2009-10-02 2011-04-07 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Sanitizing compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188900A (en) * 1985-04-04 1987-10-14 Int Genetic Sciences Fusogenic phospholipid vesicles
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080003273A1 (en) * 2006-06-29 2008-01-03 Kimberly-Clark Worldwide, Inc. Transdermal Delivery of Oleocanthal for Relief of Inflammation
KR20080016186A (en) * 2006-08-18 2008-02-21 조봉상 Cosmetic composition comprising coenzyme A, L-carnitine and caffeine mixture having a lipolytic function, IJUF-1 and white willow foil extract having a natural peeling function.
WO2011039630A1 (en) * 2009-10-02 2011-04-07 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Sanitizing compositions

Also Published As

Publication number Publication date
US20150174068A1 (en) 2015-06-25
WO2013039994A2 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
WO2016090287A3 (en) Transdermal cannabinoid formulations
WO2011153477A3 (en) Uses and compositions for treatment of hidradenitis suppurativa (hs)
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
MX2022008277A (en) Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof.
WO2012131623A3 (en) Fractional cosmetic treatment process using a laser or microneedles
WO2012040707A3 (en) Materials and methods for improving gastrointestinal function
WO2011100425A3 (en) Methods and compositions for wound healing
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
WO2011130302A3 (en) Method of treating obesity using antioxidant inflammation modulators
EP4014951A4 (en) Structure for promoting transdermal absorption, preparation method therefor, and cosmetic composition comprising same
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
WO2013055689A8 (en) R(+)-n-methyl-propargyl-aminoindan
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2014153385A3 (en) Methods of treating metabolic disorders
WO2012107887A3 (en) Process for applying a hair care composition to hair
WO2011115489A3 (en) Spray-pumpable composition suitable for topical skin application
WO2012058091A3 (en) Aripiprazole compositions and methods for its transdermal delivery
WO2013067531A3 (en) Methods of using microrna 195 in providing neuroprotection
WO2013006757A3 (en) Reconstitution device
WO2013060707A3 (en) Cosmetic agents containing oxytocin and aromatic substances
WO2013070670A8 (en) Device for tendon and ligament treatment
WO2010009056A3 (en) Pain relieving patch
WO2016182277A3 (en) Transdermal delivery method for bioactive substance using nanodiamond

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12832332

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12832332

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14344455

Country of ref document: US

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载